Study of the Effects of the Pulsed-Dye Laser at 585nm and 595nm to Treat Post-Operative Scars on Suture-Removal Day

This study has been completed.
Sponsor:
Collaborator:
Anonymous
Information provided by:
University of Miami
ClinicalTrials.gov Identifier:
NCT00482144
First received: June 1, 2007
Last updated: NA
Last verified: May 2007
History: No changes posted
  Purpose

The purpose of this study is to compare the effects of the pulsed-dye laser (PDL) at two different wavelengths, 585nm and 595nm, in the treatment of post-surgical scars starting on suture-removal day.


Condition Intervention
Cicatrix
Scars
Procedure: Pulsed-Dye Laser

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Treatment
Official Title: Comparison of the Effectiveness of the Pulsed Dye Laser 585nm Versus 595nm in the Treatment of New Surgical Scars

Resource links provided by NLM:


Further study details as provided by University of Miami:

Primary Outcome Measures:
  • Vancouver Scar Scale, Visual Analog Scale [ Time Frame: 9 months ]

Enrollment: 19
Study Start Date: July 2003
Study Completion Date: July 2005
Detailed Description:

Many treatment modalities have been used for the treatment of scars such as dermabrasion, cryotherapy, intralesional corticosteroids, surgical scar revision, and lasers, among others. Previous studies have shown that treatment of scars with the pulsed dye laser (PDL) alone or in combination with other modalities (e.g. corticosteroids, 5-Fluoruracil, silicone sheets) improves the vascularity, pliability, color, and height of hypertrophic scars and keloids. Currently, the PDL has become the laser of choice for the treatment of scars.

To our knowledge, there are no reports in the literature comparing the effects of different wavelengths of the PDL for the treatment of scars. The objective of this study was to compare the effects of the PDL at 585nm vs 595nm in the treatment of postsurgical linear scars starting the day of suture removal.

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Age 18-65
  • Postoperative linear scars greater than 6 cm
  • Skin photo-types I-IV

Exclusion Criteria:

  • Patient should not be taking any systemic, topical, or intralesional treatment of the scars
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00482144

Locations
United States, Florida
University of Miami Sylvester Comprehensive Cancer Center
Miami, Florida, United States, 33136
Sponsors and Collaborators
University of Miami
Anonymous
Investigators
Principal Investigator: Keyvan Nouri, MD University of Miami
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00482144     History of Changes
Other Study ID Numbers: 1999-0694
Study First Received: June 1, 2007
Last Updated: June 1, 2007
Health Authority: United States: Institutional Review Board

Keywords provided by University of Miami:
Pulsed-Dye Laser

Additional relevant MeSH terms:
Cicatrix
Fibrosis
Pathologic Processes

ClinicalTrials.gov processed this record on August 26, 2014